Article
Strategies for clinical implementation of screening for hereditary cancer syndromes.
Seminars in oncology - 1 Oct 2016
Heald Brandie, Marquard Jessica, Funchain Pauline
Abstract excerpt
Hereditary cancer syndromes generally account for 5%-10% of malignancies. While these syndromes are rare, affected patients carry significantly elevated risks of developing cancer, as do their at-risk relatives. Identification of these patients is critical to ensure timely and appropriate genetic testing relevant to cancer patients and their relatives. Several guidelines and tools are available to assist...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
